Orthofix Medical (OFIX) Stock Forecast, Price Target & Predictions
OFIX Stock Forecast
Orthofix Medical stock forecast is as follows: an average price target of $24.00 (represents a 27.19% upside from OFIX’s last price of $18.87) and
OFIX Price Target
Orthofix Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 08, 2024 | Mathew Blackman | Stifel Nicolaus | $24.00 | $18.22 | 31.72% | 27.19% |
| Jun 28, 2022 | Mathew Blackman | Stifel Nicolaus | $31.00 | $24.11 | 28.55% | 64.28% |
The latest Orthofix Medical stock forecast, released on Nov 08, 2024 by Mathew Blackman from Stifel Nicolaus, set a price target of $24.00, which represents a 31.72% increase from the stock price at the time of the forecast ($18.22), and a 27.19% increase from OFIX last price ($18.87).
Orthofix Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 1 |
| Avg Price Target | $24.00 | $24.00 | $24.00 |
| Last Closing Price | $18.87 | $18.87 | $18.87 |
| Upside/Downside | 27.19% | 27.19% | 27.19% |
In the current month, the average price target of Orthofix Medical stock is $24.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 27.19% increase as opposed to Orthofix Medical's last price of $18.87. This month's average price target is down 0.00% compared to last quarter, and down 0.00% compared to last year.
Orthofix Medical Financial Forecast
Orthofix Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $200.41M | $184.01M | $187.02M | $175.20M | $122.23M | $114.00M | $118.07M | $106.42M | $125.06M | $112.43M | $121.39M | $105.59M | $117.62M | $110.98M | $73.14M | $104.82M | $121.49M | $113.50M |
| Avg Forecast | $241.70M | $222.25M | $225.22M | $211.87M | $227.10M | $209.20M | $211.20M | $199.41M | $212.83M | $196.52M | $195.22M | $184.13M | $200.30M | $185.80M | $184.89M | $168.46M | $144.96M | $114.00M | $118.25M | $104.35M | $125.00M | $113.31M | $108.34M | $95.61M | $118.00M | $86.59M | $50.87M | $105.86M | $123.00M | $117.82M |
| High Forecast | $242.33M | $222.83M | $225.80M | $212.42M | $227.69M | $209.75M | $211.76M | $199.93M | $213.34M | $196.53M | $195.22M | $184.13M | $202.65M | $186.01M | $185.37M | $168.90M | $145.34M | $114.00M | $118.25M | $104.35M | $125.00M | $113.31M | $108.34M | $95.61M | $118.00M | $86.59M | $50.87M | $105.86M | $123.00M | $117.82M |
| Low Forecast | $240.69M | $221.32M | $224.28M | $210.98M | $226.15M | $208.33M | $210.32M | $198.58M | $212.33M | $196.52M | $195.22M | $184.13M | $199.26M | $185.60M | $184.12M | $167.75M | $144.36M | $114.00M | $118.25M | $104.35M | $125.00M | $113.31M | $108.34M | $95.61M | $118.00M | $86.59M | $50.87M | $105.86M | $123.00M | $117.82M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 4 | 4 | 5 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.99% | 1.01% | 1.04% | 0.84% | 1.00% | 1.00% | 1.02% | 1.00% | 0.99% | 1.12% | 1.10% | 1.00% | 1.28% | 1.44% | 0.99% | 0.99% | 0.96% |
Orthofix Medical's average Quarter revenue forecast for Mar 24 based on 4 analysts is $184.13M, with a low forecast of $184.13M, and a high forecast of $184.13M. OFIX's average Quarter revenue forecast represents a -8.13% decrease compared to the company's last Quarter revenue of $200.41M (Dec 23).
Orthofix Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 4 | 4 | 5 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-14.60M | $-20.88M | $-36.63M | $-54.90M | $-4.48M | $-357.00K | $16.00K | $-1.20M | $-871.00K | $5.92M | $13.67M | $2.73M | $14.74M | $15.19M | $-8.99M | $13.39M | $8.03M | $-19.59M |
| Avg Forecast | $1.21M | $1.11M | $1.12M | $1.06M | $1.13M | $1.04M | $1.05M | $995.68K | $1.06M | $981.28K | $974.77K | $13.94M | $1.00M | $927.76K | $923.18K | $14.91M | $-922.13K | $1.90M | $12.88M | $1.74M | $2.09M | $1.89M | $1.81M | $15.95M | $1.97M | $1.45M | $849.87K | $7.36M | $2.05M | $1.97M |
| High Forecast | $1.21M | $1.11M | $1.13M | $1.06M | $1.14M | $1.05M | $1.06M | $998.29K | $1.07M | $981.29K | $974.77K | $16.73M | $1.01M | $928.76K | $925.59K | $17.89M | $-737.71K | $1.90M | $15.45M | $1.74M | $2.09M | $1.89M | $1.81M | $19.14M | $1.97M | $1.45M | $849.87K | $8.84M | $2.05M | $1.97M |
| Low Forecast | $1.20M | $1.11M | $1.12M | $1.05M | $1.13M | $1.04M | $1.05M | $991.53K | $1.06M | $981.26K | $974.77K | $11.15M | $994.97K | $926.76K | $919.33K | $11.93M | $-1.11M | $1.90M | $10.30M | $1.74M | $2.09M | $1.89M | $1.81M | $12.76M | $1.97M | $1.45M | $849.87K | $5.89M | $2.05M | $1.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -14.59% | -22.50% | -39.68% | -3.68% | 4.86% | -0.19% | 0.00% | -0.69% | -0.42% | 3.12% | 7.55% | 0.17% | 7.47% | 10.50% | -10.57% | 1.82% | 3.91% | -9.95% |
1 analysts predict OFIX's average Quarter EBITDA for Sep 22 to be $1.90M, with a high of $1.90M and a low of $1.90M. This is 11803.43% upper than Orthofix Medical's previous annual EBITDA (Jun 22) of $16.00K.
Orthofix Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 4 | 4 | 5 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-22.17M | $-28.86M | $-39.43M | $-60.94M | $-7.06M | $-10.72M | $2.49M | $-4.46M | $-32.81M | $-2.17M | $2.42M | $-5.82M | $-9.38M | $4.65M | $-18.42M | $25.66M | $11.69M | $-40.50M |
| Avg Forecast | $769.76K | $-8.47M | $-8.85M | $-13.86M | $-1.92M | $-7.44M | $-8.72M | $-12.70M | $-10.39M | $-13.28M | $-14.05M | $-29.74M | $2.32M | $-8.08M | $-23.18M | $-31.81M | $-34.74M | $4.44M | $2.99M | $285.15K | $6.46M | $4.66M | $4.18M | $-34.02M | $7.58M | $-11.92M | $-33.99M | $14.12M | $22.15M | $19.39M |
| High Forecast | $772.38K | $-8.42M | $-8.80M | $-13.78M | $-1.91M | $-7.40M | $-8.68M | $-12.63M | $-6.93M | $-13.21M | $-13.97M | $-23.80M | $8.11M | $-8.04M | $-23.06M | $-25.45M | $-27.79M | $4.44M | $3.58M | $285.15K | $6.46M | $4.66M | $4.18M | $-27.22M | $7.58M | $-11.92M | $-33.99M | $16.94M | $22.15M | $19.39M |
| Low Forecast | $765.58K | $-8.50M | $-8.88M | $-13.90M | $-1.93M | $-7.47M | $-8.75M | $-12.74M | $-13.86M | $-13.32M | $-14.10M | $-35.69M | $-3.64M | $-8.11M | $-23.26M | $-38.17M | $-41.69M | $4.44M | $2.39M | $285.15K | $6.46M | $4.66M | $4.18M | $-40.83M | $7.58M | $-11.92M | $-33.99M | $11.29M | $22.15M | $19.39M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -9.56% | 3.57% | 1.70% | 1.92% | 0.20% | -2.42% | 0.83% | -15.64% | -5.08% | -0.47% | 0.58% | 0.17% | -1.24% | -0.39% | 0.54% | 1.82% | 0.53% | -2.09% |
Orthofix Medical's average Quarter net income forecast for Sep 22 is $4.44M, with a range of $4.44M to $4.44M. OFIX's average Quarter net income forecast represents a 78.22% increase compared to the company's last Quarter net income of $2.49M (Jun 22).
Orthofix Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 4 | 4 | 5 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $132.28M | $122.08M | $133.43M | $142.60M | $84.79M | $74.78M | $75.73M | $73.47M | $75.36M | $72.41M | $75.67M | $67.23M | $72.21M | $69.47M | $58.53M | $72.18M | $80.42M | $75.89M |
| Avg Forecast | $161.88M | $148.85M | $150.84M | $141.90M | $152.10M | $140.11M | $141.45M | $133.55M | $142.55M | $131.62M | $130.75M | $123.32M | $134.15M | $124.44M | $123.83M | $112.82M | $79.78M | $76.35M | $90.88M | $69.89M | $83.72M | $75.89M | $72.56M | $64.04M | $79.03M | $57.99M | $34.07M | $39.70M | $82.38M | $78.91M |
| High Forecast | $162.30M | $149.24M | $151.23M | $142.27M | $152.50M | $140.48M | $141.82M | $133.90M | $142.88M | $131.62M | $130.75M | $123.32M | $135.72M | $124.58M | $124.15M | $113.12M | $95.74M | $76.35M | $109.06M | $69.89M | $83.72M | $75.89M | $72.56M | $64.04M | $79.03M | $57.99M | $34.07M | $47.64M | $82.38M | $78.91M |
| Low Forecast | $161.20M | $148.23M | $150.21M | $141.31M | $151.47M | $139.53M | $140.86M | $133.00M | $142.21M | $131.62M | $130.75M | $123.32M | $133.46M | $124.31M | $123.31M | $112.35M | $63.83M | $76.35M | $72.70M | $69.89M | $83.72M | $75.89M | $72.56M | $64.04M | $79.03M | $57.99M | $34.07M | $31.76M | $82.38M | $78.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.98% | 1.08% | 1.26% | 1.06% | 0.98% | 0.83% | 1.05% | 0.90% | 0.95% | 1.04% | 1.05% | 0.91% | 1.20% | 1.72% | 1.82% | 0.98% | 0.96% |
Orthofix Medical's average Quarter SG&A projection for Mar 24 is $123.32M, based on 4 Wall Street analysts, with a range of $123.32M to $123.32M. The forecast indicates a -6.78% fall compared to OFIX last annual SG&A of $132.28M (Dec 23).
Orthofix Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 4 | 4 | 5 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-594.48 | $-0.77 | $-1.07 | $-1.71 | $-0.35 | $-0.53 | $0.12 | $-0.22 | $-1.65 | $-0.11 | $0.12 | $-0.30 | $-0.49 | $0.24 | $-0.96 | $1.33 | $0.61 | $-2.14 |
| Avg Forecast | $0.02 | $-0.22 | $-0.23 | $-0.36 | $-0.05 | $-0.19 | $-0.23 | $-0.33 | $-0.27 | $-0.34 | $-0.36 | $-0.51 | $0.06 | $-0.21 | $-0.60 | $-0.51 | $0.34 | $0.12 | $0.04 | $0.01 | $0.17 | $0.12 | $0.11 | $0.02 | $0.20 | $-0.31 | $-0.89 | $0.11 | $0.58 | $0.51 |
| High Forecast | $0.02 | $-0.22 | $-0.23 | $-0.36 | $-0.05 | $-0.19 | $-0.23 | $-0.33 | $-0.18 | $-0.34 | $-0.36 | $-0.50 | $0.21 | $-0.21 | $-0.60 | $-0.50 | $0.34 | $0.12 | $0.04 | $0.01 | $0.17 | $0.12 | $0.11 | $0.02 | $0.20 | $-0.31 | $-0.89 | $0.11 | $0.58 | $0.51 |
| Low Forecast | $0.02 | $-0.22 | $-0.23 | $-0.36 | $-0.05 | $-0.19 | $-0.23 | $-0.33 | $-0.36 | $-0.35 | $-0.37 | $-0.51 | $-0.09 | $-0.21 | $-0.60 | $-0.51 | $0.34 | $0.12 | $0.04 | $0.01 | $0.17 | $0.12 | $0.11 | $0.02 | $0.20 | $-0.31 | $-0.89 | $0.11 | $0.58 | $0.51 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -9869.67% | 3.67% | 1.78% | 3.37% | -1.03% | -4.54% | 2.82% | -29.33% | -9.71% | -0.90% | 1.09% | -14.30% | -2.43% | -0.77% | 1.07% | 11.74% | 1.05% | -4.20% |
According to 1 Wall Street analysts, Orthofix Medical's projected average Quarter EPS for Sep 22 is $0.12, with a low estimate of $0.12 and a high estimate of $0.12. This represents a -2.78% decrease compared to OFIX previous annual EPS of $0.12 (Jun 22).
Orthofix Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SGHT | Sight Sciences | $3.73 | $9.00 | 141.29% | Hold |
| LUNG | Pulmonx | $6.20 | $11.93 | 92.42% | Buy |
| ATEC | Alphatec | $9.93 | $16.94 | 70.59% | Buy |
| RXST | RxSight | $44.81 | $70.11 | 56.46% | Buy |
| KIDS | OrthoPediatrics | $25.50 | $39.60 | 55.29% | Buy |
| LIVN | LivaNova | $50.05 | $70.50 | 40.86% | Buy |
| NPCE | NeuroPace | $9.19 | $12.88 | 40.15% | Buy |
| BRKR | Bruker | $53.37 | $73.75 | 38.19% | Buy |
| CNMD | CONMED | $70.69 | $96.00 | 35.80% | Buy |
| OFIX | Orthofix Medical | $18.87 | $24.00 | 27.19% | - |
| CVRX | CVRx | $13.52 | $16.33 | 20.78% | Buy |
| IRMD | IRadimed | $52.08 | $60.00 | 15.21% | Buy |
| FNA | Paragon 28 | $10.35 | $11.50 | 11.11% | Buy |
| ITGR | Integer | $133.37 | $138.00 | 3.47% | Buy |
| GMED | Globus Medical | $83.59 | $79.54 | -4.85% | Buy |
| GKOS | Glaukos | $141.44 | $123.44 | -12.73% | Buy |